Johns Hopkins Study Identifies Neuroprotective Role of Biliverdin Reductase A in Combating Oxidative Stress

A recent study conducted by researchers at Johns Hopkins Medicine has identified a previously unknown neuroprotective role of the enzyme biliverdin reductase A (BVRA). The research highlights that BVRA, traditionally recognized for its enzymatic function in converting biliverdin into bilirubin—a pigment with established antioxidant properties—also plays a significant role in shielding the brain from oxidative stress-related damage. This discovery adds to the understanding of BVRA’s functions and its potential impact on brain health.

The study reveals that BVRA not only contributes to bilirubin production but also actively protects neural cells from oxidative stress, which is known to contribute to various neurological disorders. Oxidative stress occurs when there is an imbalance between free radicals and antioxidants in the body, leading to cellular damage. The findings suggest that BVRA may act as a critical defense mechanism within the brain, mitigating harmful effects caused by this imbalance. Researchers emphasize that this dual functionality of BVRA could have implications for future studies focused on neurodegenerative diseases and other conditions linked to oxidative stress.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 3, 2025

Author

GOAI